JOURNAL OF PEPTIDE SCIENCE

metrics 2024

Discovering the intricacies of peptide synthesis and function.

Introduction

JOURNAL OF PEPTIDE SCIENCE, published by Wiley, is a vital resource for researchers and professionals in the fields of biochemistry, drug discovery, and molecular biology. Established in 1995 and encompassing research through 2024, this journal provides a platform for disseminating cutting-edge studies related to peptide synthesis, structure, function, and applications in therapeutics. Although it currently does not offer open access, its robust content has earned it a respectable Q3 ranking in several categories, including biochemistry and pharmacology, according to the latest metrics. Researchers will find significant insights linked to peptide chemistry and its implications in medical sciences, making the JOURNAL OF PEPTIDE SCIENCE an essential addition to academic libraries and for those passionate about peptide research and its potential breakthroughs.

Metrics 2024

SCIMAGO Journal Rank0.35
Journal Impact Factor1.80
Journal Impact Factor (5 years)1.80
H-Index73
Journal IF Without Self1.80
Eigen Factor0.00
Normal Eigen Factor0.17
Influence0.33
Immediacy Index0.40
Cited Half Life9.40
Citing Half Life9.10
JCI0.36
Total Documents2198
WOS Total Citations2287
SCIMAGO Total Citations11820
SCIMAGO SELF Citations769
Scopus Journal Rank0.35
Cites / Document (2 Years)1.74
Cites / Document (3 Years)1.76
Cites / Document (4 Years)1.74

Metrics History

Rank 2024

Scopus

Organic Chemistry in Chemistry
Rank #132/211
Percentile 37.44
Quartile Q3
Pharmacology in Pharmacology, Toxicology and Pharmaceutics
Rank #196/313
Percentile 37.38
Quartile Q3
Structural Biology in Biochemistry, Genetics and Molecular Biology
Rank #33/49
Percentile 32.65
Quartile Q3
Drug Discovery in Pharmacology, Toxicology and Pharmaceutics
Rank #105/157
Percentile 33.12
Quartile Q3
Biochemistry in Biochemistry, Genetics and Molecular Biology
Rank #307/438
Percentile 29.91
Quartile Q3
Molecular Medicine in Biochemistry, Genetics and Molecular Biology
Rank #132/178
Percentile 25.84
Quartile Q3
Molecular Biology in Biochemistry, Genetics and Molecular Biology
Rank #311/410
Percentile 24.15
Quartile Q4

IF (Web Of Science)

BIOCHEMISTRY & MOLECULAR BIOLOGY
Rank 259/313
Percentile 17.40
Quartile Q4
CHEMISTRY, ANALYTICAL
Rank 69/106
Percentile 35.40
Quartile Q3

JCI (Web Of Science)

BIOCHEMISTRY & MOLECULAR BIOLOGY
Rank 269/313
Percentile 14.06
Quartile Q4
CHEMISTRY, ANALYTICAL
Rank 80/106
Percentile 24.53
Quartile Q4

Quartile History

Similar Journals

Journal of Molecular Structure

Bridging knowledge and discovery in molecular science.
Publisher: ELSEVIERISSN: 0022-2860Frequency: 24 issues/year

Journal of Molecular Structure is a premier publication in the field of chemistry, offering a platform for innovative research that spans analytical, inorganic, organic chemistry, and spectroscopy. Published by Elsevier in the Netherlands, this journal is committed to advancing the understanding of molecular architecture and behavior through high-quality, peer-reviewed articles. With its impressive impact factor and a notable Scopus ranking placing it in the top quartiles among its peers, it serves as an essential resource for researchers, professionals, and students alike. The journal's open access options promote the dissemination of knowledge, ensuring that groundbreaking discoveries reach a broad audience. Established in 1967 and projected to continue through 2025, the Journal of Molecular Structure is vital for anyone engaged in the study of molecular interactions and structural analysis.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Pioneering Research in Enzyme Inhibition
Publisher: TAYLOR & FRANCIS LTDISSN: 1475-6366Frequency: 1 issue/year

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, published by Taylor & Francis Ltd, is a premier open-access journal that has been at the forefront of research in the field of medicinal chemistry since its inception in 1985. With an ISSN of 1475-6366 and an E-ISSN of 1475-6374, this journal boasts a prestigious reputation reflected in its impressive Q1 rankings across critical categories such as Drug Discovery and Pharmacology as of 2023. Situated in the United Kingdom, it plays a vital role in disseminating high-quality research that addresses the burgeoning needs of drug discovery and enzyme inhibition methodologies. The journal supports full open access, providing a platform for researchers, professionals, and students to share significant findings and innovations widely. With a robust impact factor, the JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY is indispensable for any academic or professional involved in the pharmacological sciences, offering an unparalleled insight into the latest advancements in therapeutic strategies and drug development.

BIOPHYSICAL CHEMISTRY

Unveiling the complexities of protein folding and beyond.
Publisher: ELSEVIERISSN: 0301-4622Frequency: 12 issues/year

BIOPHYSICAL CHEMISTRY, published by Elsevier, is a prestigious journal with a long-standing tradition since its inception in 1973. This highly respected journal focuses on the intersections of biochemistry, biophysics, and organic chemistry, providing a critical platform for researchers, professionals, and students to disseminate pivotal findings in these dynamic fields. With an impressive impact factor that reflects its robust academic influence and high citation rates, it ranks within the Q2 quartile among its peers in multiple categories, indicating its significance in the scholarly community. The journal, hosted in the Netherlands, encompasses a diverse range of topics, from molecular interactions to protein folding, and serves as an essential resource for those engaged in cutting-edge research. Researchers looking to share their work with a global audience will find BIOPHYSICAL CHEMISTRY an invaluable outlet, fostering the advancement of knowledge in this crucial area of science. For more information, visit the journal's page on the Elsevier platform.

Open Chemistry

Empowering the Global Chemistry Community Through Open Research
Publisher: DE GRUYTER POLAND SP Z O OISSN: 2391-5420Frequency: 1 issue/year

Open Chemistry, published by DE GRUYTER POLAND SP Z O O, is a distinguished peer-reviewed journal that has been serving the global chemistry community since its inception. With an ISSN of 2391-5420 and an E-ISSN also of 2391-5420, this open-access journal has been accessible to researchers and practitioners alike since 2015, ensuring a wide dissemination of high-quality research findings. Located in Germany, specifically at BOGUMILA ZUGA 32A STR, 01-811 WARSAW, MAZOVIA, POLAND, Open Chemistry aims to publish innovative research across various chemical disciplines, with special attention to miscellaneous chemistry and materials chemistry. It is currently ranked in the Q3 category for both fields as of 2023, reflecting its solid standing within the academic community, with specific ranks of 187/408 in General Chemistry and 153/317 in Materials Chemistry, corresponding to respective percentiles of 54 and 51. Open Chemistry not only enhances the accessibility of cutting-edge research but also serves as a vital resource for students, professionals, and scholars seeking to advance their knowledge in the rapidly evolving landscape of chemical sciences.

Future Medicinal Chemistry

Pioneering research for tomorrow's therapeutic breakthroughs.
Publisher: Newlands Press LtdISSN: 1756-8919Frequency: 24 issues/year

Future Medicinal Chemistry is a premier journal dedicated to the rapidly evolving fields of drug discovery, pharmacology, and molecular medicine. Published by Newlands Press Ltd in the United Kingdom, this journal has garnered significant attention within the academic community, evidenced by its 2023 category rankings in Scopus, placing it in the Q2 quartile for Drug Discovery and the Q3 quartiles for both Molecular Medicine and Pharmacology. With an ISSN of 1756-8919 and an E-ISSN of 1756-8927, Future Medicinal Chemistry has been a cornerstone of scholarly discourse since its inception in 2009, continuously contributing to the advancement of knowledge and discussion in medicinal chemistry. The journal is committed to publishing high-quality, peer-reviewed research that addresses the challenges and innovations in drug development and therapeutic strategies, making it an essential resource for researchers, professionals, and students seeking to stay at the forefront of these critical fields. Engage with the latest findings and methodologies that shape the future of medicine by exploring the wealth of information offered within Future Medicinal Chemistry.

RSC Medicinal Chemistry

Unlocking the Future of Drug Design and Discovery
Publisher: ROYAL SOC CHEMISTRYISSN: Frequency: 12 issues/year

RSC Medicinal Chemistry is a pivotal journal in the realm of medicinal chemistry, published by the esteemed Royal Society of Chemistry. With a focus on innovative research that intersects various disciplines such as biochemistry, drug discovery, pharmaceutical science, and organic chemistry, this journal serves as a vital resource for researchers, professionals, and students alike. Its impressive impact factor and notable rankings—positioning it within the Q1 and Q2 quartiles across critical categories—underscore its significance in advancing knowledge and fostering collaboration within the scientific community. RSC Medicinal Chemistry is dedicated to open access, ensuring that cutting-edge findings on drug design and therapeutic applications are freely available to enhance global research efforts. With a commitment to publication excellence from 2020 to 2024, it is a prominent platform where groundbreaking ideas meet practical implications, making it indispensable for anyone committed to the forefront of medicinal advances.

JOURNAL OF THE CHINESE CHEMICAL SOCIETY

Fostering Knowledge in the Evolving World of Chemistry
Publisher: WILEY-V C H VERLAG GMBHISSN: 0009-4536Frequency: 12 issues/year

JOURNAL OF THE CHINESE CHEMICAL SOCIETY, published by WILEY-V C H VERLAG GMBH, is a vital resource in the field of chemistry, focusing on a broad array of topics pertinent to general chemistry and its advancing sub-disciplines. Established in 1954 and running through 2024, this journal serves as a significant platform for the dissemination of high-quality research, showcasing innovative findings and developments within the chemical sciences. With its Q3 category ranking and positioning at Rank #203 in General Chemistry per Scopus, it reflects the journal's commitment to research excellence and impact. While not an open-access publication, it ensures accessibility to a global audience, making it an essential tool for researchers, professionals, and students alike seeking to stay informed and engaged in the evolving landscape of chemistry.

Molbank

Fostering Innovative Research in Molecular Science
Publisher: MDPIISSN: Frequency: 4 issues/year

Molbank is an open-access journal published by MDPI, dedicated to the fields of Biochemistry, Organic Chemistry, and Physical and Theoretical Chemistry. Established in 2002, this journal has served as a vital platform for the dissemination of research findings, where researchers and professionals share original articles focusing on molecular chemistry, synthesis, and related studies. With a commitment to open access, Molbank enables global access to scientific knowledge, fostering collaboration and innovation among scientists. While currently categorized in the fourth quartile for its field rankings, it provides a unique opportunity for emerging scholars to contribute to and engage with the scientific community. The journal is based in Switzerland, operating from its office at ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND, and continues to attract submissions until 2024. Researchers, students, and professionals looking to expand their knowledge and participate in the dialogue of current molecular chemistry can benefit significantly from engaging with the content published in Molbank.

HETEROATOM CHEMISTRY

Exploring the Unseen: Advancing Heteroatom Chemistry
Publisher: WILEY-HINDAWIISSN: 1042-7163Frequency: 1 issue/year

Heteroatom Chemistry is a prominent open-access journal dedicated to advancing the field of heteroatom chemistry, with a particular focus on the chemistry of elements other than carbon in organic compounds. Published by Wiley-Hindawi, this journal provides researchers, professionals, and students with a platform to disseminate and access novel research findings related to the synthesis, properties, and applications of heteroatom-containing compounds. Since its inception in 1990 and gaining open access status in 2019, the journal has fostered academic collaboration and innovation throughout its converged years, although it currently holds a category quartile ranking of Q4 in Chemistry (miscellaneous) and ranks #319 out of 408 in general chemistry within Scopus. With its commitment to high-quality research and broad accessibility, Heteroatom Chemistry is poised to be an essential resource for anyone looking to explore the rich and varied applications of heteroatom chemistry in diverse scientific fields.

CURRENT MEDICINAL CHEMISTRY

Elevating Research Standards in Medicinal Chemistry.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 0929-8673Frequency: 42 issues/year

Current Medicinal Chemistry is a leading journal published by Bentham Science Publishers Ltd, known for its rigorous focus on the multifaceted realm of medicinal chemistry. With an ISSN of 0929-8673 and E-ISSN 1875-533X, the journal plays a crucial role in disseminating high-quality research findings that bridge the gap between chemistry and health sciences. Operating from Sharjah, United Arab Emirates, it has been a prominent scholarly resource since its inception in 1994, and is expected to continue until 2024. Current Medicinal Chemistry has earned its place in the academic community with an impressive impact factor and categorization in Q1 and Q2 quartiles across various disciplines, including Organic Chemistry, Biochemistry, Drug Discovery, and Pharmacology, highlighting its substantial contribution to these fields. Notably, it ranks 24th in Organic Chemistry and is within the 88th percentile, underscoring its appeal to researchers, professionals, and students alike who are keen on exploring cutting-edge advancements in drug design and development. Although it is not an open-access journal, it provides vital content that informs and inspires innovation in medicinal chemistry, appealing to a global audience committed to enhancing human health through scientific discovery.